SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-20-000063
Filing Date
2020-06-01
Accepted
2020-06-01 16:56:18
Documents
2
Period of Report
2020-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159104495703408.html 4  
1 FORM 4 wf-form4_159104495703408.xml 4 4073
2 POA - BURGESS poa-burgess.htm EX-24 3327
  Complete submission text file 0001447028-20-000063.txt   8955
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
BURGESS DANIEL D (Reporting) CIK: 0001239650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 20934052

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations